TENAX THERAPEUTICS INC (TENX)
US88032L6056 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -7.71M | -11.05M | -32.47M | -9.85M | -8.39M | |||
| Depreciation Amortization | 7.57K | 10.00K | 0.00 | 0.00 | 10.00K | |||
| Income Taxes - Deferred | N/A | N/A | N/A | N/A | N/A | |||
| Change In Working Capital | 1.61M | -1.44M | -610.00K | 100.00K | 460.00K | |||
| Interest Paid | N/A | N/A | N/A | N/A | N/A | |||
| Taxes Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other non cash items | 191.98K | 470.00K | 22.22M | 470.00K | 370.00K | |||
| OPERATING CASH FLOW | -5.90M | -12.01M | -10.86M | -9.27M | -7.56M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | 0.00 | -10.00K | 0.00 | 0.00 | |||
| Other Investing Activity | 2.84K | 0.00 | 460.00K | 20.00K | 0.00 | |||
| INVESTING CASH FLOW | 2.84K | 0.00 | 450.00K | 20.00K | 0.00 | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -624.30K | 620.00K | 0.00 | 240.00K | N/A | |||
| Stock Issued/Repurchased | 1.16K | 0.00 | 9.74M | 10.35M | 100.00K | |||
| Other Financing Activity | 14.19M | 7.93M | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | 13.57M | 8.55M | 9.74M | 10.60M | 100.00K | |||
| CHANGE IN CASH | 7.67M | -3.46M | -670.00K | 1.35M | -7.46M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -5.90M | -12.01M | -10.86M | -9.27M | -7.56M | |||
| Capital Expenditure | N/A | 0.00 | -10.00K | 0.00 | 0.00 | |||
| FREE CASH FLOW | -5.90M | -12.01M | -10.87M | -9.27M | -7.56M | |||
All data in USD